期刊文献+

mTOR基因在人肝癌组织中的表达 被引量:2

Expression and significance of mTOR gene in human hepatocellular carcinoma
原文传递
导出
摘要 目的观察人肝癌组织哺乳类动物雷帕霉素靶蛋白(mTOR)基因的表达。方法应用半定量逆转录-聚合酶链反应(RT-PCR)方法检测10例人中晚期肝癌及其癌旁正常组织中mTORmRNA的相对表达量,并采用Westernblot检测上述组织中mTOR蛋白产物表达。结果90%(9/10)的肝癌组织中mTORmRNA和蛋白表达增强,而癌旁组织中80%(8/10)该基因表达缺失和蛋白表达减少,两者差异有统计学意义(P〈0.05)。结论中晚期肝癌中mTOR表达处于活化状态,可能在肝癌的发生、发展过程中发挥重要作用。 Objective To investigate the expression of mammalian target of rapamycin (mTOR) gene in human hepatoeellular carcinoma (hHCC). Methods The samples were obtained from 10 cases of hHCC tissues. Semi-quantitative RT-PCR and Western blot were used to detect the InTOR mRNA and protein expression in 10 samples and adjacent noncanerous tissues. Results mTOR mRNA and protein expression was detected in 90 % of hHCC tissues and of 20% adjacent noncanerous tissues ( P 〈 0.05 ). Conclusion mTOR activation might be in hHCC. mTOR gene may play some roles in the pathogenesis of HCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第10期1270-1271,共2页 Chinese Journal of Experimental Surgery
关键词 肝细胞 MTOR 基因表达 Carcinoma,hepatoceUular mTOR Gene expression
  • 相关文献

参考文献4

  • 1Sehmelzle T, Hall MN. TOR, a central controller of cell growth. Cell, 2000,103:253 -262.
  • 2Sinars CR, Cheung-Flynn J, Rimerman RA,et al. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci USA ,2003, 100:868-873.
  • 3Mickael O,An drew KS,Thomas L,et al. Atrophy of S6KI ( -/- ) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol ,2005,7:286-294.
  • 4Fingar DC, Salama S,Tsou C,et al. Mammalian cell size is controlled by roTOR and its downstream targets S6K1 and 4EBP1/elF4E. Genes Dev,2002,16 : 1472-1487.

同被引文献28

  • 1米登海,罗好曾,陈学鹏,张文华,陈瑞萍.肝癌遗传模式与危险因素病例-对照研究[J].中国公共卫生,2006,22(7):849-850. 被引量:19
  • 2Forner A, L|ovet JM, Bruix J. Hepatocellular carcinoma [ J ]. Lancet, 2012,379 ( 9822 ) : 1245 - 1255.
  • 3Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening [ J ]. Semin Liver Dis ,2005,25 (2) : 143 - 154.
  • 4Marrero JA,Fontana RJ,Fu S, et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma [ J ]. J Hepato1,2005,42 (2) :218 - 224.
  • 5Yu MC, Yuan JM. Environmental factors and risk for hepatocel- lular carcinoma[ J ]. Gastroenterology, 2004,127 ( 5 Snppl 1 ) : S72 - 78.
  • 6Slattery ML, Herrick JS, Lundgreen A, et al. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3 K and Aktl [ J ]. Carcinogenesis ,2010,31 ( 9 ) : 1604 - 1611.
  • 7Huang LZ, Huang J, Wu P, et al. Association of genetic varia- tions in mTOR with risk of childhood acute lymphoblastic leuke- mia in a Chinese population [ J ]. Leukemia and Lymphoma, 2012,53(5) :947 -951.
  • 8He J, Wang MY, Qiu LX, et al. Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population [ J ]. Molecular Carcinogenesis,2013,52 ( suppl 1 ) :70 - 79.
  • 9Zhu ML, Yu HP, Shi TY, et al. Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in Eastern Chinese populations [ J ]. J Thorac Oncol, 2013,8 ( 6 ) : 788 - 795.
  • 10Advani SH. Targeting mTOR pathway:a new concept in cancer therapy [ J ]. Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical and Paediatric On- cology ,2010,31 (4) : 132 - 136.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部